Atnaujinta: 2024.07.23 01:09 (GMT+3)

Tallinna Farmaatsiatehas: Balance sheet, as at 30.09.2001

2001.11.30, Tallinna Farmaatsiatehas, TLN
TALLINNA FARMAATSIATEHAS
BALANCE SHEET

BALANCE SHEET, AS AT 30.09.2001

Consolidated/unaudited
in thousand EEK
31.12.2000 30.09.2001
A S S E T S

CURRENT ASSETS
Cash and bank accounts 715 1,296
Customer receivables
ACCOUNTS RECEIVABLE 4,979 4,020
ALLOWANCE FOR DOUBTFUL RECEIVABLES
RESERVE - -
Total 4,979 5,316
Other receivables
RECEIVABLES FROM PARENT COMPANY 30,375 19,285
OTHER SHORT-TERM RECEIVABLES 98 139
Total 30,473 19,425

Accrued income 37 0

Prepaid expenses 582 573

Inventories
RAW MATERIAL 12,134 8,445
WORK-IN-PROGRESS 565 802
FINISHED GOODS 11,654 15,887
PREPAYMENTS TO SUPPLIERS 1,331 1,668
Total 25,684 26,802

TOTAL CURRENT ASSETS 62,471 52,117

NON-CURRENT ASSETS

Long-term investments 449 449

Fixed assets
FIXED ASSETS IN NET BOOK VALUE 33,636 32,450
CONSTRUCTION IN PROGRESS 119 5,614
Total 33,755 38,064

Intangible assets 3,216 2,785

TOTAL NON-CURRENT ASSETS 37,420 41,297

TOTAL ASSETS 99,891 93,414


LIABILITIES AND SHAREHOLDERS’ EQUITY

LIABILITIES
CURRENT LIABILITIES
CURRENT PORTION OF LONG-TERM DEBT 7,703 2,172
SHORT-TERM BANK LOANS 496 153
Total 8,200 2,326

Customers prepayments - -
Accounts payable 13,714 8,885
Other payables 3,882 999
Taxes payable 701 395

Accrued expenses 2,364 2,046

TOTAL CURRENT LIABILITIES 28,860 14,652

NON-CURRENT LIABILITIES
Long-term debt obligations
BANK LOANS 24,055 27,324
PAYABLES TO PARENT COMPANY 24,351 24,351

TOTAL NON-CURRENT LIABILITIES 48,406 51,675

TOTAL LIABILITIES 77,266 66,327

SHAREHOLDERS’ EQUITY
SHARE CAPITAL 12,500 12,500
RESERVES 2,316 2,316
RETAINED EARNINGS
(ACCUMULATED DEFICIT) -2,779 7,808
PROFIT (LOSS) FOR FINANCIAL YEAR 10,587 4,469
SHAREHOLDERS’ EQUITY TOTAL 22,625 27,088

LIABILITIES AND SHAREHOLDERS’ EQUITY 99,891 93,414


Raivo Unt
Management Board member
+372 612 0201

Vertybiniai popieriai

Akcijos
Obligacijos
Fondai

Rinkos informacija

Statistika
Prekyba
Indeksai
Aukcionai

Reguliavimas

Taisyklės ir nuostatos
Priežiūra

Kaip pradėti

Įmonėms
Investuotojams
Nariams
First North sertifikuotiems PATARĖJAMS

Naujienos

Nasdaq naujienos
Emitento naujienos
Kalendorius

Apie mus

Nasdaq Baltijos rinkoje
Biurai